Skip to content

Public FDA record

Z-0810-05: Bio-Intact PTH (1-84) Assay, Catalog No. 62-7040

Recall record Z-0810-05 for Nichols Institute Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0810-05
Company in FDA record
Nichols Institute Diagnostics
FDA classification date
May 10, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Values do not agree with Directional Instructions.

Source facts

Action
Firm sent separate notices for each lot of product to customers dated March 25, 2005 requesting destruction of remaining product and affirmation of that activity via a response form. Users were also provided detailed listing of performance characteristics related to the deficiencies for thier information and evaluation per thier own lab''s SOP''s.
Initiated
2005-04-07
Root cause
Other
Terminated
2012-03-16
Distribution
Nationwide and to Australia, Canada, Chile, France, Germany, Greece, Italy, japan, Spain, Sweden
Recall number
Z-0810-05
Recall status
Terminated
CDRH record ID
38404
FDA classified
2005-05-10
Recall event number
31730

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗